UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: DiklofenakOrifarm25Enterotablett-SE-PLC-RA

Generated Narrative: RegulatedAuthorization DiklofenakOrifarm25Enterotablett-SE-PLC-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/19694

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00019694,http://ema.europa.eu/fhir/eurdId#1048; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Gastro-resistant tablet; indication = Diklofenak Orifarm 25 mg enterotablett är indicerat för behandling av nedanstående och är avsedd för vuxna och barn över 6 år. Reumatoid artrit. Juvenil reumatoid artrit. Artros. Mb. Bechterew. Dysmenorré utan organisk orsak.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = diclofenac

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2005-05-27

holder: Organization Orifarm Generics A/S

Cases

-TypeDate[x]
*First Authorisation2005-05-27